Health Care & Life Sciences » Pharmaceuticals | Lansen Pharmaceutical Holdings Ltd.

Lansen Pharmaceutical Holdings Ltd. | Cash Flow

Fiscal year is January-December. All values HKD Thousands.
2013
2014
2015
2016
2017
2018
Net Income before Extraordinaries
116,977.90
140,111.60
33,576.40
54,539.00
132,828.60
16,380.50
Depreciation, Depletion & Amortization
18,957.20
25,730.00
26,289.00
26,733.90
28,287.90
28,834.30
Other Funds
33,989.60
23,775.90
14,776.40
14,911.70
96,412.70
23,042.40
Funds from Operations
101,945.50
142,065.80
74,641.80
66,361.20
64,703.80
22,172.40
Changes in Working Capital
61,851.50
41,402.20
6,186.60
84,579.70
23,931.70
2,508
Net Operating Cash Flow
40,094.10
100,663.50
68,455.20
18,218.50
88,635.50
24,680.40
Capital Expenditures
70,430.30
104,843.30
55,710.00
36,196.30
31,685.60
Sale of Fixed Assets & Businesses
488.70
46.50
193.80
7.80
3,023.60
Purchase/Sale of Investments
-
-
-
64,832.00
121,232.80
Net Investing Cash Flow
94,390.60
194,968.20
55,516.20
103,232.90
92,570.90
Cash Dividends Paid - Total
76,969.20
68,442.80
50,523.50
41,583.50
94,433.40
Issuance/Reduction of Debt, Net
126,518.60
200,489.60
54,632.40
138,117.40
70,564.00
Net Financing Cash Flow
49,549.40
132,046.70
4,108.90
96,533.90
164,997.30
Net Change in Cash
2,730.30
37,144.90
10,938.90
30,133.90
19,754.80
Free Cash Flow
9,199.40
79,276.10
39,887.00
36,817.30
71,460.10
Net Assets from Acquisitions
-
-
-
2,212.30
-
Other Sources
20,710.20
8,227.70
-
-
-
Exchange Rate Effect
2,016.70
597.10
6,109.00
5,216.40
3,545.70
Other Uses
45,159.20
98,399.20
-
-
-

About Lansen Pharmaceutical Holdings

View Profile
Address
228 Xinfeng Road
Ningbo Zhejiang 315174
China
Employees -
Website http://www.lansen.com.cn
Updated 07/08/2019
Lansen Pharmaceutical Holdings Ltd. engages in the development, manufacture, and distribution of pharmaceuticals products. It operates through the following segments: Pharmaceuticals, Medicinal Cosmetics Products, and Healthcare Products. The Pharmaceuticals segment develops, produces, and sells specialty pharmaceuticals mainly used in the field of rheumatology and dermatology and other pharmaceuticals.